MISSION

"Our mission is to improve the lives of patients the world over by delivering comprehensive solutions that optimize outcomes for the key stakeholders in our health system – patients, providers & payers"

Altrazeal Life Sciences Inc. is a specialty medical technology company committed to developing and commercializing drug delivery systems based on our patented technologies.

PRODUCTS

Wound Healing Technology: Altrazeal®

Altrazeal® Transforming Powder Dressing is scientifically engineered to optimize the wound bed environment and accelerate healing. Produced as a sterile powder, Altrazeal® is unique in application and performance on a moist wound surface. When applied to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the powder to aggregate irreversibly and form a moist wound dressing which conforms to the surface of a wound bed and seals the wound.

Transmucosal Drug Delivery: OraDisc

A novel, patented, cost-effective, commercially-viable, water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort, is easy to apply and capable of providing tailored erosion rates to deliver therapeutics over different time intervals.

GLOBAL PRESENCE

Altrazeal Transforming Powder Dressing is available in all states across the United States and in 17 countries across Europe, the Middle East, and Latin America.

MISSION

"Our mission is to improve the lives of patients the world over by delivering comprehensive solutions that optimize outcomes for the key stakeholders in our health system – patients, providers & payers"

Altrazeal Life Sciences Inc. is a specialty medical technology company committed to developing and commercializing drug delivery systems based on our patented technologies.

PRODUCTS

Wound Healing Technology: Altrazeal®

Altrazeal® Transforming Powder Dressing is scientifically engineered to optimize the wound bed environment and accelerate healing. Produced as a sterile powder, Altrazeal® is unique in application and performance on a moist wound surface. When applied to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the powder to aggregate irreversibly and form a moist wound dressing which conforms to the surface of a wound bed and seals the wound.

Transmucosal Drug Delivery: OraDisc

A novel, patented, cost-effective, commercially-viable, water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort, is easy to apply and capable of providing tailored erosion rates to deliver therapeutics over different time intervals.

GLOBAL PRESENCE

Altrazeal Transforming Powder Dressing is available in all states across the United States and in 17 countries across Europe, the Middle East, and Latin America.

Natalia Kirsten

MD

Global Research Advisor

LEADERSHIP:

– Senior Physician, Institute for Services in Health Care Research in Dermatology and Nursing

– Former Resident, Department of Dermatology, Professor Carle Paul Larrey Hospital University of Toulouse, France

EDUCATION:

– University of Hamburg

Natalia Kirsten

mD

Global Research Advisor

LEADERSHIP:

– Senior Physician, Institute for Services in Health Care Research in Dermatology and Nursing

– Former Resident, Department of Dermatology, Professor Carle Paul Larrey Hospital University of Toulouse, France

EDUCATION:

– University of Hamburg

Lawrence A. Lavery

dPM, MPH

Professor, Plastic Surgery, UT Southwestern Medical Center

LEADERSHIP:

– Medical Director, Diabetic Limb Salvage Program, Parkland Hospital

– Member, International Working Group on the Diabetic Foot

– Past chair of the American Diabetes Association Foot Care Counsel and the American Public Health Association’s Foot Section

EDUCATION:

– University of Texas Health Science Center, Dr. William Scholl College of Podiatric Medicine, Indiana University

Lawrence A. Lavery

dPM, MPH

Professor, Plastic Surgery, UT Southwestern Medical Center

LEADERSHIP:

– Medical Director, Diabetic Limb Salvage Program, Parkland Hospital

– Member, International Working Group on the Diabetic Foot

– Past chair of the American Diabetes Association Foot Care Counsel and the American Public Health Association’s Foot Section

EDUCATION:

– University of Texas Health Science Center, Dr. William Scholl College of Podiatric Medicine, Indiana University